Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2023-07-15
2023-12-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A. Orientation/Baseline Testing (Visit #1) After voluntarily signed IRB-approved consent forms, study participants will be tested for maximal aerobic capacity (VO2max) during a graded, cycling test with continuous metabolic monitoring with the Cosmed CPET metabolic device (Cosmed, Rome, Italy). Body composition will be measured with the seca BIA and Bod Pod body composition analyzer (Life Measurement, Concord, CA). Demographic and training histories will be acquired with questionnaires.
B. Pre-Supplementation Lab Visit #2 and 2-Week Supplementation Protocol: Two weeks prior to the first cycling session, subjects will report to the Human Performance Laboratory at approximately 7:00-8:00 am. A blood sample will be collected in an overnight fasted state to coincide with the same time of the day for the post-supplementation blood draw. A 2-week supply of POSSIBLE Beet Pre-Workout supplement or placebo supplement will be given to the participants. Subjects will mix the supplement powder in one cup of cold water and consume one dose in the early morning and a second dose mid-day.
POSSIBLE Beet Pre-Workout supplement (subjects will consume 2 scoops per day, 28 grams total, with one dose in the early morning, and the second dose mid-day). Note: the placebo will include excipients only, with none of the ingredients listed below.
Ingredients (per 14 g scoop dose) Beets: Beets in combination with fermented beets to provide nitrates (106 mg of nitrates per serving).
Caffeine (100 mg) from Green Tea Extract. Camu Camu to provide vitamin C (22 mg or 25% of the Daily Value). Camu camu is a sour berry native to the Amazon rainforest that has a high vitamin C content.
Quinoa Sprouts: Source of B-vitamins and will provide 20% of the Daily Value for thiamin, riboflavin, niacin, and vitamin B6. Quinoa is a plant with edible seeds that are rich in B vitamins.
Mushroom Blend of three common mushrooms (1.5 g evenly divided from Hericium erinaceus or lion's mane mushroom, Cordyceps sinensis or caterpillar fungus, and Inonotus obliquus or chaga). These three mushrooms may support exercise performance, but more scientific evidence is needed.
C. 2.25 h Cycling Session (Lab Visit #3): During the 3-day period prior to the 2.25-h cycling session, subjects will taper exercise training and ingest a moderate-carbohydrate diet using a food list restricting high fat foods, visible fats, caffeine, and polyphenols (1,2). Study participants will report to the Human Performance Lab in an overnight fasted state and provide a blood sample, ingest the supplement (POSSIBLE Beet Pre-Workout supplement or placebo), and then cycle 2.25 h at high intensity (70% VO2max) while ingesting water alone (3 ml/kg every 15 minutes). Blood samples will be collected at 0 h, 1.5 h, 3.0 h, and 24 h post-exercise.
Testing protocol during the lab sessions with the 2.25-h cycling session:
1. 7:00 am: Provide blood sample, delayed onset of muscle soreness (DOMS) rating (1-10 scale), and profile of mood states ratings (POMS).
2. 7:10 am: Ingest supplement with 1 cup water.
3. 7:30 am: Start the 2.25 h cycling session. Subjects will cycle on trainers at 70% VO2max (\~race pace) for 2.25 hours. Oxygen consumption, carbon dioxide production, respiratory exchange ratio, and ventilation will be measured using the Cosmed Quark CPET metabolic cart every 30 minutes. Subjects will consume 3 ml/kg water every 15 min. No other beverage or food containing energy or nutrients will be allowed during the 2.25-h exercise sessions.
4. \~10:00 am to 1:00 pm: Blood samples will be taken via venipuncture immediately after completing the cycling session, and then 1.5-h and 3.0-h post-exercise. Subjects will be allowed to shower and change clothes. The DOMS and POMS questionnaires will be administered each time blood samples are collected. Subjects will ingest no food or beverage other than water (7 ml/kg during the 1.5 h post-exercise period). After the 1.5 h post-exercise blood draw, subjects will ingest a Boost beverage (8 kcal/kg body weight). Another blood sample will be collected 3-h post-exercise. Afterwards, subjects will be allowed to leave the lab with instructions to adhere to the food list requirements, and to keep exercise training moderate.
5. 7:00 am, next morning: 24-h blood sample and DOMS and POMS ratings (Lab visit #4).
D. Washout/Crossover/Repeat Subjects will engage in a 2-week washout period without the supplements, crossover to the opposite treatment arm, and then repeat all procedures (Lab visits #5,6,7).
STATISTICAL ANALYSIS AND POWER CALCULATION The study participant number (N = 20) will provide 84% power to detect a difference with an effect size 0.7 at alpha 0.05 using 2-sided paired t-tests (5). Data will be checked for normality of the residuals using Q-Q plots. All data will be analyzed using the generalized linear model (GLM), and a 2 (condition) x 6 (time) repeated-measures ANOVA, within-participants design (IBM SPSS Statistics for Windows, Version 24.0, IBM Corp, Armonk, NY, USA). Changes over time within conditions will be contrasted between trials using paired t-tests, with the alpha level set at p,0.01. Principle component analysis (PCA) and heatmap analysis of the oxylipin data will be performed with the R programming language (https://www.r-project.org/, version 3.3.1).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Beet
Powdered beets with green tea extract, Camu Camu, Quinoa sprouts, 3 mushroom blend.
Beet
Beet-based powder with other ingredients
Placebo
Similar colored powder with no active ingredients.
Placebo
Placebo powder.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beet
Beet-based powder with other ingredients
Placebo
Placebo powder.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-smoker, and generally healthy and without chronic disease including cardiovascular disease (e.g., heart disease, stroke), cancer, type 1 and 2 diabetes, rheumatoid arthritis. Categorized as "low risk" using the American College of Sports Medicine screening questionnaire.
* Agree to train normally, maintain weight, and avoid the regular use of large-dose vitamin and mineral supplements, herbs, and medications that influence inflammation (especially NSAIDs) for the duration of the 6-week study and at least a 2-week period prior to the study.
* Agree to limit intake of nitrate-rich vegetables during the study to less than 1 cup per day. These include spinach, lettuce, beets, beetroot juice, celery, and cabbage.
* Agree to taper their exercise routine prior to each of the two lab cycling sessions.
* Agree to avoid the use of mouthwashes, antacids, and chewing gum during the entire 6-week study and the 2-week period prior to the study.
Exclusion Criteria
* Females: body weight below 110 pounds; trying to become pregnant, pregnant or breastfeeding.
* Any other concurrent condition which, in the opinion of the principal investigator (PI), would preclude participation in this study or interfere with compliance.
* Current diagnosis of cardiovascular disease, diabetes, or cancer (except for non-melanoma skin cancer).
* An unwillingness to avoid mouthwashes, antacids, and chewing gum 2 weeks before and during the 6-week study.
* An unwillingness to limit intake of nitrate-rich vegetables 2 weeks before and during the 6-week study.
* Current history of uncontrolled hypertension and/or the use of vasodilatory medications.
* Sensitivity to caffeine intake from green tea extract (200 mg per day).
* History of allergic reactions to any of the ingredients in the study supplement: beet powder, camu camu, green tea extract, mushroom blend (caterpillar fungus, lion's mane, chaga), quinoa sprouts, monk fruit, pineapple, cranberry seed powder, strawberry fruit powder).
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Standard Process
UNKNOWN
Appalachian State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David C Nieman, DrPH
Role: PRINCIPAL_INVESTIGATOR
Appalachian State Univ
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Appalachian State University Human Performance Lab, North Carolina Research Campus
Kannapolis, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS-23-297
Identifier Type: -
Identifier Source: org_study_id